ATE442364T1 - Kristalline form von linezolid - Google Patents

Kristalline form von linezolid

Info

Publication number
ATE442364T1
ATE442364T1 AT03769887T AT03769887T ATE442364T1 AT E442364 T1 ATE442364 T1 AT E442364T1 AT 03769887 T AT03769887 T AT 03769887T AT 03769887 T AT03769887 T AT 03769887T AT E442364 T1 ATE442364 T1 AT E442364T1
Authority
AT
Austria
Prior art keywords
crystalline form
linezolide
linezolid
preparation
relates
Prior art date
Application number
AT03769887T
Other languages
English (en)
Inventor
Rao Dodda Mohan
Reddy Pingili Krishna
Original Assignee
Symed Labs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE442364(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Symed Labs Ltd filed Critical Symed Labs Ltd
Application granted granted Critical
Publication of ATE442364T1 publication Critical patent/ATE442364T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT03769887T 2003-10-16 2003-10-16 Kristalline form von linezolid ATE442364T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000336 WO2005035530A1 (en) 2003-10-16 2003-10-16 A novel crystalline form of linezolid

Publications (1)

Publication Number Publication Date
ATE442364T1 true ATE442364T1 (de) 2009-09-15

Family

ID=34430675

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03769887T ATE442364T1 (de) 2003-10-16 2003-10-16 Kristalline form von linezolid

Country Status (10)

Country Link
US (4) US7714128B2 (de)
EP (3) EP2902386B1 (de)
AT (1) ATE442364T1 (de)
AU (1) AU2003278592A1 (de)
DE (2) DE09163348T1 (de)
DK (1) DK1673370T3 (de)
ES (3) ES2331001T3 (de)
HU (1) HUE051230T2 (de)
PT (1) PT1673370E (de)
WO (1) WO2005035530A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003278592A1 (en) 2003-10-16 2005-04-27 Symed Labs Limited A novel crystalline form of linezolid
EP1737850B1 (de) 2004-04-19 2007-10-03 Symed Labs Limited Neues verfahren zur herstlelung von linezolid und verwandten verbindungen
JP2007504173A (ja) * 2004-06-29 2007-03-01 テバ ファーマシューティカル インダストリーズ リミティド リネゾリドのｉｖ型結晶
MX2007000084A (es) * 2004-06-29 2007-06-14 Teva Pharma Formas solidas de linezolid y procesos para la preparacion delas mismas.
EP1866295A2 (de) 2005-02-24 2007-12-19 Teva Pharmaceutical Industries Ltd Verfahren zur herstellung von linezolidzwischenprodukten
DK1749517T3 (da) 2005-07-20 2008-11-03 Teva Pharma Stabil farmaceutiske sammensætning af linezolid form IV
EP2033960A3 (de) 2007-09-04 2009-04-29 Dipharma Francis S.r.l. Kristalline Linezolidhydratform und Linezolidsalze
IT1390957B1 (it) * 2008-07-07 2011-10-27 Dipharma Francis Srl Sali di linezolid e loro uso nella preparazione di forme cristalline di linezolid
WO2009032294A2 (en) * 2007-09-06 2009-03-12 Teva Pharmaceutical Industries Ltd. Processes for the preparation of a linezolid intermediate, linezolid hydroxide
WO2009140466A2 (en) * 2008-05-14 2009-11-19 Dr. Reddy's Laboratories Ltd. Linezolid co-crystals
WO2011050826A1 (en) * 2009-10-28 2011-05-05 Synthon B.V. Process for making crystalline form a of linezolid
EP2493867A1 (de) 2009-10-28 2012-09-05 Synthon BV Verfahren zur herstellung einer kristallinen form von linezolid
CA2785620A1 (en) 2009-12-26 2011-06-30 Alembic Pharmaceuticals Limited Process for the preparation of linezolid
EP2603506A1 (de) 2010-08-11 2013-06-19 Synthon BV Verfahren zur herstellung von linezolid
EP2603505A1 (de) 2010-08-11 2013-06-19 Synthon BV Verfahren zur herstellung von linezolid
US9132132B2 (en) 2010-09-02 2015-09-15 Hetero Research Foundation Pharmaceutical compositions of linezolid
CN102070548B (zh) * 2011-01-13 2012-12-26 浙江新东港药业股份有限公司 一种晶型ⅰ型利奈唑胺的蒸发结晶工艺
EP2593440A1 (de) 2011-02-24 2013-05-22 Lee Pharma Limited Kristalline form ii von wasserfreiem linezolid
WO2012119653A1 (en) 2011-03-09 2012-09-13 Synthon Bv Process for making crystalline form a of linezolid
CN105461648B (zh) * 2011-05-03 2018-01-12 江苏豪森药业集团有限公司 利奈唑胺的晶型及其制备方法
ITMI20111311A1 (it) * 2011-07-14 2013-01-15 Dipharma Francis Srl Sali di linezolid e loro uso nella preparazione di forme cristalline di linezolid
WO2013072923A1 (en) * 2011-09-19 2013-05-23 Cadila Healthcare Limited Process for the preparation of crystalline linezolid
WO2013093751A1 (en) * 2011-12-24 2013-06-27 Alembic Pharmaceuticals Limited Packaging for linezolid
US20150025236A1 (en) * 2012-01-24 2015-01-22 Jubilant Life Sciences Limited Process for the preparation of stable crystalline form-i of linezolid, substantially free of residual solvent
WO2013120496A1 (en) 2012-02-14 2013-08-22 Pharmathen S.A. Process for the preparation of linezolid in crystalline form and salts thereof
WO2013190559A1 (en) * 2012-06-19 2013-12-27 Symed Labs Limited Improved processes for the preparation of linezolid crystalline form iii
WO2014033744A2 (en) 2012-08-10 2014-03-06 Indoco Remedies Limited A novel pharmaceutical composition of linezolid
ES2603252T3 (es) 2012-11-09 2017-02-24 Synthon Bv Proceso para preparar linezolid
WO2014118809A1 (en) 2013-01-29 2014-08-07 Actavis Group Ptc Ehf. Pharmaceutical composition with linezolid
IN2013MU03508A (de) 2013-11-06 2015-07-24 Unimark Remedies Ltd
CN105254580B (zh) * 2014-04-22 2018-01-02 江苏豪森药业集团有限公司 利奈唑胺晶型的制备方法
WO2016113751A1 (en) * 2015-01-13 2016-07-21 Nosch Labs Private Limited Process for preparing crystalline linezolid form-iii
WO2018051360A1 (en) * 2016-09-16 2018-03-22 Lee Pharma Limited A novel process for the preparation of crystalline linezolid form-iii
US20190343761A1 (en) 2016-11-16 2019-11-14 Persica Pharmaceuticals Ltd. Antibiotic formulations for lower back pain
PL3709970T3 (pl) 2017-11-16 2025-09-08 Persica Pharmaceuticals Ltd. Preparaty linezolidu
CN110194750A (zh) * 2019-06-19 2019-09-03 四川美大康华康药业有限公司 一种利奈唑胺的制备方法及精制方法
JP2024537142A (ja) 2021-10-12 2024-10-10 ペルシカ ファーマシューティカルズ リミテッド 腰痛治療

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US583870A (en) * 1897-06-01 Wrench
DE2810349A1 (de) 1978-03-10 1979-09-20 Kali Chemie Pharma Gmbh Verfahren zur herstellung von 3-hydroxy-6-phenyl-1,2,3,4-tetrahydro- 1,5-benzodiazocinen
FR2506769A2 (fr) 1978-06-09 1982-12-03 Delalande Sa Para-((cyano-5 n pentyl-1) phenyl)-3 methoxymethyl-5 oxazolidinone-2, son procede de preparation et ses applications en therapeutique
US4340606A (en) 1980-10-23 1982-07-20 E. I. Du Pont De Nemours And Company 3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents
FR2608604B1 (fr) 1986-12-19 1989-04-28 Delalande Sa Derives 5-hydroxyethyles de l'oxazolidinone-2, leurs procedes de preparation et leurs applications en therapeutique
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
DE9310451U1 (de) 1993-03-05 1994-06-30 Landis & Gyr Business Support Ag, Zug Steuer- bzw. Regeleinrichtung für Gas-Feuerungsautomaten von Heizungsanlagen
DE59306401D1 (de) 1993-03-11 1997-06-12 Landis & Gyr Tech Innovat Brennerregler
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
MY115155A (en) * 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
ATE209193T1 (de) 1996-04-11 2001-12-15 Upjohn Co Verfahren zur herstellung von oxazolidinonen
EP0890791A1 (de) 1997-07-11 1999-01-13 Electrowatt Technology Innovation AG Steuer- und Regelgerät für einen Brenner
EE04370B1 (et) 1997-11-07 2004-10-15 Pharmacia & Upjohn Company Oksasolidinoonide valmistamismeetod, meetodis kasutatavad vaheühendid ja nende valmistamine
US6444813B2 (en) 2000-02-02 2002-09-03 Pharmacia & Upjohn Company Linezolid-crystal form II
AR027261A1 (es) 2000-02-02 2003-03-19 Upjohn Co Linezolid forma cristalina ii
MY127336A (en) 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
DE10037585A1 (de) * 2000-08-02 2002-02-14 Valeo Schalter & Sensoren Gmbh Rückstellvorrichtung für einen Blinkerschalter in Kraftfahrzeugen
NZ524554A (en) 2000-08-14 2005-07-29 Teva Pharma Preparation of risperidone
MXPA03006958A (es) * 2001-02-05 2003-11-18 Upjohn Co Composicion para administracion rectal de farmaco antibacterial de oxazolidinona.
NZ528996A (en) * 2001-04-20 2006-01-27 Upjohn Co Process to prepare oxazolidinones
CN1155585C (zh) 2001-12-19 2004-06-30 中国医学科学院医药生物技术研究所 3,5－取代噁唑烷酮衍生物及其制备方法和应用
US6992219B2 (en) 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
AU2003278592A1 (en) 2003-10-16 2005-04-27 Symed Labs Limited A novel crystalline form of linezolid
EP1737850B1 (de) 2004-04-19 2007-10-03 Symed Labs Limited Neues verfahren zur herstlelung von linezolid und verwandten verbindungen
JP2007504173A (ja) 2004-06-29 2007-03-01 テバ ファーマシューティカル インダストリーズ リミティド リネゾリドのｉｖ型結晶
US7429661B2 (en) 2004-07-20 2008-09-30 Symed Labs Limited Intermediates for linezolid and related compounds

Also Published As

Publication number Publication date
DK1673370T3 (da) 2009-12-07
EP2902386A1 (de) 2015-08-05
DE09163348T1 (de) 2010-01-07
US7732597B2 (en) 2010-06-08
US7718800B2 (en) 2010-05-18
US7718799B2 (en) 2010-05-18
DE60329237D1 (de) 2009-10-22
US20060128703A1 (en) 2006-06-15
WO2005035530A1 (en) 2005-04-21
US20080090820A1 (en) 2008-04-17
AU2003278592A1 (en) 2005-04-27
EP2902386B1 (de) 2020-04-08
ES2331001T3 (es) 2009-12-18
HUE051230T2 (hu) 2021-03-01
US20080090824A1 (en) 2008-04-17
EP2100884A1 (de) 2009-09-16
ES2803516T3 (es) 2021-01-27
PT1673370E (pt) 2009-11-05
US20080091011A1 (en) 2008-04-17
ES2331454T1 (es) 2010-01-05
EP1673370B1 (de) 2009-09-09
EP1673370A1 (de) 2006-06-28
US7714128B2 (en) 2010-05-11

Similar Documents

Publication Publication Date Title
ATE442364T1 (de) Kristalline form von linezolid
DE60315368D1 (de) Korrektur des Weissabgleichs
CO5611137A2 (es) Composiciones de clorhidrato de naltrexona
CY2013036I2 (el) Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων
DE60333020D1 (de) Anzeigeeinrichtung des dünnen typs
EP1633307A4 (de) Modulation der survivin-expression
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
DK1603524T3 (da) Enzymholdig oral sammensætning med forbedret stabilitet
IS7716A (is) Hringlaga heterósambönd
DK1613304T3 (da) DPP-IV-inhibitorer
IL159418A0 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
NO20034410L (no) Vaksinesammensetning
ATE428701T1 (de) Kristalline form von bisä(e)-7-ä4-(4-fluorphenyl)-6-isopropyl-2-
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
BR0307071A (pt) ésteres hidroxamato do ácido n-(fenil 4-substituìdo)-antranìlico
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
DE60333205D1 (de) Histaminika zur behandlung von allergischer rhinitis
DE60201084D1 (de) Herstellung von cyclischen esteroligomeren
DE50213650D1 (de) Einrichtung zur Herstellung von Stapelpaketen
ATE444290T1 (de) Oxazolderivate von tetracyclinen
DE60107074D1 (de) Kristallin form ii von cabergolin
ATE527280T1 (de) Fluoreszentprotein und chromoprotein
DK1644385T3 (da) Siliciumforbindelser og deres anvendelse
ATE474824T1 (de) Herstellung von olefinen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1673370

Country of ref document: EP